Researchers have uncovered how the breakdown of glycogen may protect the brain from neurodegeneration and Alzheimer's.

A global microbiome preservation effort dubbed “Microbial Noah’s Ark” entered a new phase and announced the creation of ...

Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and ...

Vetter has invested approximately $285 million in the new Des Plaines clinical manufacturing site, which is expected to open ...

A membrane transport protein called SLC13A5 has previously been linked to a severe form of epileptic encephalopathy.

EM, researchers elucidated the structure of key receptors integral to fast excitatory synaptic transmission in the rat ...

The open benchmark competition will evaluate the ability of AI-powered virtual cell models to generalize to new cell contexts ...

Iya Khalil, PhD, discusses Merck & Co.’s approach to artificial intelligence (AI), and success in applying the technology, ...

When the macrophages’ ability to consume dying cancer cells or Upd3 production was decreased, tumor growth was significantly ...

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

Moving toward clinical development, the researchers demonstrated efficient delivery of mRNA mitochondrial base editors using ...

An iPSC-based ALS-on-a-chip model that mimics disease progression and reveals altered glutamate signaling in motor neurons ...